Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
(Source: Abbott.com)
Source: Abbott.com - April 17, 2024 Category: Pharmaceuticals Source Type: news
Abbott Receives FDA Approval for TriClip ™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
(Source: Abbott.com)
Source: Abbott.com - April 2, 2024 Category: Pharmaceuticals Source Type: news
Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
(Source: Abbott.com)
Source: Abbott.com - April 1, 2024 Category: Pharmaceuticals Source Type: news
Abbott Hosts Conference Call for First-Quarter Earnings
(Source: Abbott.com)
Source: Abbott.com - March 27, 2024 Category: Pharmaceuticals Source Type: news
Abbott Receives CE Mark for its Groundbreaking Assert-IQ ™ Insertable Cardiac Monitor, Expanding Availability of Long-Term Monitoring for Irregular Heart Rhythms
(Source: Abbott.com)
Source: Abbott.com - March 25, 2024 Category: Pharmaceuticals Source Type: news
Real-World Data Show Abbott's FreeStyle Libre ® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes
(Source: Abbott.com)
Source: Abbott.com - March 6, 2024 Category: Pharmaceuticals Source Type: news
Abbott Extends Innovative Health Partnership with Real Madrid and the Real Madrid Foundation
(Source: Abbott.com)
Source: Abbott.com - March 4, 2024 Category: Pharmaceuticals Source Type: news
Abbott Declares 401st Consecutive Quarterly Dividend
(Source: Abbott.com)
Source: Abbott.com - February 16, 2024 Category: Pharmaceuticals Source Type: news
FDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip ™ System to Treat People With a Leaky Tricuspid Heart Valve
(Source: Abbott.com)
Source: Abbott.com - February 13, 2024 Category: Pharmaceuticals Source Type: news
New Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate Again
(Source: Abbott.com)
Source: Abbott.com - February 1, 2024 Category: Pharmaceuticals Source Type: news
Abbott Launches New PROTALITY ™ Brand to Support Adults on Their Weight Loss Journey
(Source: Abbott.com)
Source: Abbott.com - January 31, 2024 Category: Pharmaceuticals Source Type: news
Abbott Launches World's Smallest Rechargeable System With Remote Programming Capabilities to Treat Movement Disorders ¹+
(Source: Abbott.com)
Source: Abbott.com - January 25, 2024 Category: Pharmaceuticals Source Type: news
Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
(Source: Abbott.com)
Source: Abbott.com - January 24, 2024 Category: Pharmaceuticals Source Type: news
Abbott ’s Proclaim™ DRG Neurostimulation System Offers Expanded MRI Access for People Suffering From Chronic Pain
(Source: Abbott.com)
Source: Abbott.com - January 18, 2024 Category: Pharmaceuticals Source Type: news
Abbott Announces First Global Procedures in a Clinical Trial of its Volt ™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
(Source: Abbott.com)
Source: Abbott.com - January 18, 2024 Category: Pharmaceuticals Source Type: news
